Form 4: ARS Pharmaceuticals Officer Exercises Stock Options, Maintains Significant Beneficial Ownership

Sarina Tanimoto, Chief Medical Officer of ARS Pharmaceuticals, exercised stock options at prices of $0.84 and $1.44, resulting in adjustments to her direct and indirect beneficial ownership of the company's common stock.

Summary

• On April 23, 2024, Sarina Tanimoto, the Chief Medical Officer of ARS Pharmaceuticals, exercised stock options to acquire shares of common stock.
• She exercised options for 82,733 shares at a price of $0.84 per share and 48,260 shares at a price of $1.44 per share.
• Following these transactions, Tanimoto directly owns 3,407,847 shares of ARS Pharmaceuticals common stock.
• She also has indirect ownership through various trusts, including the Richard Lowenthal Charitable Remainder UniTrust (1,646,494 shares), the Lowenthal-Tanimoto Family Trust (1,848,499 shares), the Sarina Tanimoto Charitable Remainder UniTrust (1,647,447 shares), and shares held by her spouse (4,315,313 shares).

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock option exercises, which is neutral in sentiment.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The stock option exercises may have a minor dilutive effect on existing shareholders.

Key Dates